A detailed history of Hrt Financial LP transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 24,770 shares of RNXT stock, worth $18,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,770
Previous 20,632 20.06%
Holding current value
$18,577
Previous $27,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$0.87 - $1.4 $3,600 - $5,793
4,138 Added 20.06%
24,770 $31,000
Q2 2025

Aug 14, 2025

BUY
$0.77 - $1.42 $15,886 - $29,297
20,632 New
20,632 $27,000
Q2 2024

Aug 12, 2024

BUY
$1.02 - $1.46 $11,977 - $17,144
11,743 New
11,743 $13,000
Q4 2023

Feb 09, 2024

BUY
$0.6 - $2.29 $8,424 - $32,153
14,041 New
14,041 $32,000

Others Institutions Holding RNXT

About RenovoRx, Inc.


  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $6.8M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.